We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+13.3%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$463M
AUM Growth
+$326M
Cap. Flow
+$324M
Cap. Flow %
69.94%
Top 10 Hldgs %
8.1%
Holding
694
New
390
Increased
110
Reduced
28
Closed
165

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$5.03M
2
NKE icon
Nike
NKE
+$4.85M
3
WMT icon
Walmart Inc
WMT
+$4.79M
4
TRU icon
TransUnion
TRU
+$3.45M
5
ODFL icon
Old Dominion Freight Line
ODFL
+$3.4M

Top Sells

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$2.99M
2
LHX icon
L3Harris
LHX
+$2.1M
3
XLNX
Xilinx Inc
XLNX
+$1.93M
4
CLGX
Corelogic, Inc.
CLGX
+$1.83M
5
BABA icon
Alibaba
BABA
+$1.51M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.69%
2 Technology 15.79%
3 Healthcare 14.21%
4 Industrials 12.25%
5 Financials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTON icon
26
Peloton Interactive
PTON
$2.77B
$2.16M 0.47%
+21,777
New +$1.6M
FDX icon
27
FedEx
FDX
$72.7B
$2.14M 0.46%
+8,500
New +$1.7M
HSY icon
28
Hershey
HSY
$35.2B
$2.08M 0.45%
+14,500
New +$2.06M
ES icon
29
Eversource Energy
ES
$26.9B
$2.06M 0.45%
+24,700
New +$2.11M
EA icon
30
Electronic Arts
EA
$53B
$2.06M 0.45%
+15,800
New +$2.15M
GGG icon
31
Graco
GGG
$12.9B
$2.06M 0.44%
+33,500
New +$1.87M
MSFT icon
32
Microsoft
MSFT
$3.45T
$2.04M 0.44%
+9,700
New +$2.04M
CSX icon
33
CSX Corp
CSX
$93.4B
$2.04M 0.44%
78,735
+47,835
+155% +$1.18M
PHM icon
34
Pultegroup
PHM
$24.1B
$2.01M 0.44%
43,500
+31,300
+257% +$1.34M
GBT
35
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.95M 0.42%
35,443
+31,243
+744% +$1.99M
NBIX icon
36
Neurocrine Biosciences
NBIX
$16.8B
$1.95M 0.42%
+20,300
New +$2.35M
IMMU
37
DELISTED
Immunomedics Inc
IMMU
$1.95M 0.42%
22,928
+12,851
+128% +$650K
SINA
38
DELISTED
Sina Corp
SINA
$1.94M 0.42%
+45,500
New +$1.83M
DELL icon
39
Dell
DELL
$262B
$1.94M 0.42%
+56,428
New +$1.76M
PSX icon
40
Phillips 66
PSX
$84.9B
$1.9M 0.41%
+36,700
New +$2.24M
TRMB icon
41
Trimble
TRMB
$13.2B
$1.89M 0.41%
+38,900
New +$1.86M
TROW icon
42
T. Rowe Price
TROW
$23.9B
$1.88M 0.41%
+14,674
New +$1.94M
SNX icon
43
TD Synnex
SNX
$20.4B
$1.86M 0.4%
26,600
+14,400
+118% +$906K
FE icon
44
FirstEnergy
FE
$28B
$1.86M 0.4%
64,750
+53,950
+500% +$1.69M
BSX icon
45
Boston Scientific
BSX
$69.5B
$1.81M 0.39%
+47,400
New +$1.83M
RSG icon
46
Republic Services
RSG
$64.8B
$1.8M 0.39%
19,300
+8,800
+84% +$787K
NVO
47
Novo Nordisk
NVO
$208B
$1.8M 0.39%
51,800
+20,600
+66% +$687K
DNKN
48
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$1.79M 0.39%
+21,900
New +$1.58M
VMW
49
DELISTED
VMware, Inc
VMW
$1.78M 0.39%
12,400
+8,100
+188% +$1.15M
ZD icon
50
Ziff Davis
ZD
$1.96B
$1.78M 0.38%
+29,555
New +$1.67M

Similar funds

Seven Eight Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Seven Eight Capital held 694 positions worth $463M, up 239% from $137M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Seven Eight Capital deployed $324M of net new capital in Q3 2020, opening 390 new positions and adding to 110 existing holdings. Its largest new stake was Nike: 45,200 shares worth $5.67M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Xilinx Inc, an estimated $1.93M trimmed.

  • Seven Eight Capital's largest Q3 2020 buy was Nike: 45,200 shares worth $5.67M.
  • Seven Eight Capital added most to Cigna in Q3 2020, an estimated $5.03M increase.
  • Seven Eight Capital's biggest Q3 2020 reduction was Xilinx Inc, cutting an estimated $1.93M.
  • Seven Eight Capital fully exited Conagra Brands in Q3 2020, selling an estimated $2.99M.
  • Seven Eight Capital's ten largest holdings make up 8.1% of its $463M portfolio in Q3 2020.
  • Seven Eight Capital opened 390 new positions and closed 165 in Q3 2020.
  • Seven Eight Capital's portfolio value rose 239% quarter-over-quarter to $463M.

Based on Seven Eight Capital's 13F filing for Q3 2020, filed 16 Nov 2020.